Skip to content

Effectiveness of percutaneous vertebroplasty in patients with osteoporotic vertebral compression fracture.

Prospective evaluation of percutaneous vertebroplasty in osteoporotic vertebral compression fracture patients. - OPVCF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027343
Enrollment
15
Registered
2020-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M800- Age-related osteoporosis with current pathological fracture

Interventions

Intervention1: percutaneous vertebroplasty: fluoroscopic guidance percutaneous vertebroplasty with polymethyl methacrylayte bone cement Control Intervention1: not applicable: not applicable

Sponsors

DrShivani Rastogi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -1-3 painful OVCF at any levels with a physical examination and radiographic findings -patients with chronic back pain ( > 12 weeks )not responding to primary treatment. -coagulation test should be normal.

Exclusion criteria

Exclusion criteria: -pedicle fracture -cord compression -patients refusal to give consent -local or systemic infection -concomitant hip fractures -osteoporotic vertebral collapse > 90 % -previous vertebroplasty -posterior vertebral body breach -significant compromise of spinal canal by retropulsed bone fragment or tumor -pregnant patients -vertebral compression fracturea patients with multiple myeloma and metstatic tumors - patient with known coagulopathy.

Design outcomes

Primary

MeasureTime frame
pain relief following percutaneous vertebroplasty.Timepoint: follow up at 1 week , 1 month, 6th month

Secondary

MeasureTime frame
improvement in vertebral height, wedge angle, corelation of pain relief with percentage of correctionTimepoint: follow up at 1 week , 1 month, 6th month

Countries

India

Contacts

Public ContactDr yasum litin

Dr.RMLIMS

neuromanu@yahoo.com8176007201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026